Trial · NCT00232141
Results by group586
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 586
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline for Numerical Rating Scale (NRS) Pain Scores at Endpoint-LOCF (Last Observation Carried Forward) Relative to Baseline | Pregabalin | -2.88 | Standard Error 0.21 | score on scale | |
| Change From Baseline for Numerical Rating Scale (NRS) Pain Scores at Endpoint-LOCF (Last Observation Carried Forward) Relative to Baseline | Placebo | -2.63 | Standard Error 0.21 | score on scale | |
| Change in NRS-Pain Scores From Baseline to Endpoint-BOCF (Modified Baseline Observation Carried Forward) | Pregabalin | Week 1 (n=136,133) | -1.14 | Standard Error 0.13 | score on scale |
| Change in NRS-Pain Scores From Baseline to Endpoint-BOCF (Modified Baseline Observation Carried Forward) | Placebo | Week 1 (n=136,133) | -0.69 | Standard Error 0.13 | score on scale |
| Change in NRS-Pain Scores From Baseline to Endpoint-BOCF (Modified Baseline Observation Carried Forward) | Pregabalin | Week 2 (n=126,132) | -1.92 | Standard Error 0.17 | score on scale |
| Change in NRS-Pain Scores From Baseline to Endpoint-BOCF (Modified Baseline Observation Carried Forward) | Placebo | Week 2 (n=126,132) | -1.43 | Standard Error 0.17 | score on scale |
| Change in NRS-Pain Scores From Baseline to Endpoint-BOCF (Modified Baseline Observation Carried Forward) | Pregabalin | Week 3 (n=118,121) | -2.36 | Standard Error 0.20 | score on scale |
| Change in NRS-Pain Scores From Baseline to Endpoint-BOCF (Modified Baseline Observation Carried Forward) | Placebo | Week 3 (n=118,121) | -1.83 | Standard Error 0.20 | score on scale |
| Change in NRS-Pain Scores From Baseline to Endpoint-BOCF (Modified Baseline Observation Carried Forward) | Pregabalin | Week 4 (n=118,124) | -2.66 | Standard Error 0.21 | score on scale |
| Change in NRS-Pain Scores From Baseline to Endpoint-BOCF (Modified Baseline Observation Carried Forward) | Placebo | Week 4 (n=118,124) | -2.24 | Standard Error 0.20 | score on scale |
| Change in NRS-Pain Scores From Baseline to Endpoint-BOCF (Modified Baseline Observation Carried Forward) | Pregabalin | Week 5 (n=116,121) | -2.79 | Standard Error 0.22 | score on scale |
| Change in NRS-Pain Scores From Baseline to Endpoint-BOCF (Modified Baseline Observation Carried Forward) | Placebo | Week 5 (n=116,121) | -2.50 | Standard Error 0.21 | score on scale |
| Change in NRS-Pain Scores From Baseline to Endpoint-BOCF (Modified Baseline Observation Carried Forward) | Pregabalin | Week 6 (n=111,119) | -2.98 | Standard Error 0.23 | score on scale |
| Change in NRS-Pain Scores From Baseline to Endpoint-BOCF (Modified Baseline Observation Carried Forward) | Placebo | Week 6 (n=111,119) | -2.45 | Standard Error 0.22 | score on scale |
| Change in NRS-Pain Scores From Baseline to Endpoint-BOCF (Modified Baseline Observation Carried Forward) | Pregabalin | Week 7 (n=112,111) | -3.22 | Standard Error 0.23 | score on scale |
| Change in NRS-Pain Scores From Baseline to Endpoint-BOCF (Modified Baseline Observation Carried Forward) | Placebo | Week 7 (n=112,111) | -2.53 | Standard Error 0.23 | score on scale |
| Change in NRS-Pain Scores From Baseline to Endpoint-BOCF (Modified Baseline Observation Carried Forward) | Pregabalin | Week 8 (n=111,111) | -3.33 | Standard Error 0.22 | score on scale |
| Change in NRS-Pain Scores From Baseline to Endpoint-BOCF (Modified Baseline Observation Carried Forward) | Placebo | Week 8 (n=111,111) | -2.58 | Standard Error 0.22 | score on scale |
| Change in NRS-Pain Scores From Baseline to Endpoint-BOCF (Modified Baseline Observation Carried Forward) | Pregabalin | Week 9 (n=107,111) | -3.09 | Standard Error 0.23 | score on scale |
| Change in NRS-Pain Scores From Baseline to Endpoint-BOCF (Modified Baseline Observation Carried Forward) | Placebo | Week 9 (n=107,111) | -2.56 | Standard Error 0.23 | score on scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00232141/results